BIOG Stock Overview
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
The Biotech Growth Trust PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£9.26 |
| 52 Week High | UK£10.34 |
| 52 Week Low | UK£7.15 |
| Beta | 0.49 |
| 1 Month Change | -5.12% |
| 3 Month Change | 1.31% |
| 1 Year Change | 19.95% |
| 3 Year Change | -36.75% |
| 5 Year Change | 35.38% |
| Change since IPO | 749.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOG | GB Capital Markets | GB Market | |
|---|---|---|---|
| 7D | -1.7% | -0.7% | 2.2% |
| 1Y | 19.9% | 6.6% | 0.9% |
Return vs Industry: BIOG exceeded the UK Capital Markets industry which returned 7% over the past year.
Return vs Market: BIOG exceeded the UK Market which returned 0.6% over the past year.
Price Volatility
| BIOG volatility | |
|---|---|
| BIOG Average Weekly Movement | 2.7% |
| Capital Markets Industry Average Movement | 4.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: BIOG has not had significant price volatility in the past 3 months.
Volatility Over Time: BIOG's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | n/a | www.biotechgt.com/index.php/biog/home/overview/ |
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe.
The Biotech Growth Trust PLC Fundamentals Summary
| BIOG fundamental statistics | |
|---|---|
| Market cap | UK£309.44m |
| Earnings (TTM) | -UK£92.02m |
| Revenue (TTM) | n/a |
-3.5x
P/S Ratio-3.4x
P/E RatioIs BIOG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOG income statement (TTM) | |
|---|---|
| Revenue | -UK£87.65m |
| Cost of Revenue | UK£0 |
| Gross Profit | -UK£87.65m |
| Other Expenses | UK£4.37m |
| Earnings | -UK£92.02m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.75 |
| Gross Margin | 100.00% |
| Net Profit Margin | 104.99% |
| Debt/Equity Ratio | 3.9% |
How did BIOG perform over the long term?
See historical performance and comparison